| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.058 | 0.05 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.06 |